• John Salmon, Dan Bates, Neels Du Toit, Paul Verrills, James Yu, Murray G Taverner, Vahid Mohabbati, Matthew Green, Gary Heit, Robert Levy, Peter Staats, Jonathan Ruais, Shilpa Kottalgi, James Makous, and Bruce Mitchell.
• Pain Care Perth and Western Australia, Pain Management, Perth, Western Australia, Australia.
• Neuromodulation. 2023 Jan 1; 26 (1): 172181172-181.

IntroductionA novel, spinal cord stimulation (SCS) system with a battery-free miniaturized implantable pulse generator (IPG) was used in this feasibility study. The system uses an external power source that communicates bidirectionally with the IPG (< 1.5 cm3). Human factors, subject comfort, and effects on low back and leg pain were evaluated in this first-in-human study.Materials And MethodsA prospective, multicenter, open-label clinical trial was initiated to evaluate the safety and performance of a novel miniaturized stimulator in the treatment of chronic, intractable leg and low-back pain. Eligible subjects were recruited for the study and gave consent. Subjects who passed the screening/trial phase (defined as ≥ 50% decrease in pain) continued to the long-term implant phase and were followed up at predefined time points after device activation. Interim clinical and usability outcomes were captured and reported at 90 days.ResultsResults of 22 subjects who chose a novel pulsed stimulation pattern therapy using the battery-free IPG (< 1.5 cm3) are described here. At 90-days follow-up, the average pain reduction was 79% in the leg (n = 22; p < 0.0001) and 76% in the low back (n = 21; p < 0.0001) compared with baseline. Responder rates (≥ 50% pain relief) at 90 days were 86% in leg pain (19/22) and 81% in low-back pain (17/21). Subjects rated the level of comfort of the external wearable power source to be 0.41 ± 0.73 at 90 days on an 11-point rating scale (0 = very comfortable, 10 = very uncomfortable).DiscussionThese interim results from the ongoing study indicate the favorable efficacy and usability of a novel, externally powered, battery-free SCS IPG (< 1.5 cm3) for leg and low-back pain. Study subjects wore the external power source continuously and found it comfortable, and the system provided significant pain relief. These preliminary findings warrant further investigation.Clinical Trial RegistrationThe Clinicaltrials.gov registration number for the study is ACTRN12618001862235.Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

16 keywords...

hide…